Lanean...

Cost Effectiveness of Romiplostim for the Treatment of Chronic Immune Thrombocytopenia in Ireland

BACKGROUND: Romiplostim, a thrombopoietin receptor agonist (TPOra), is a second-line medical treatment option for adults with chronic immune thrombocytopenia (ITP). Clinical trials have shown that romiplostim increases platelet counts, while reducing the risk of bleeding and, in turn, the need for c...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Lee, Dawn, Thornton, Patrick, Hirst, Alexander, Kutikova, Lucie, Deuson, Robert, Brereton, Nic
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer International Publishing 2013
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3824633/
https://ncbi.nlm.nih.gov/pubmed/23857462
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40258-013-0044-y
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!